[
  {
    "ts": "2025-11-28T03:13:41+00:00",
    "headline": "Kidney Disease Trial Success Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)",
    "summary": "Vertex Pharmaceuticals recently reported positive clinical trial data for povetacicept in IgA nephropathy and primary membranous nephropathy, showing significant proteinuria reduction and stabilization of kidney function, and announced plans to begin rolling regulatory submissions for potential FDA accelerated approval in 2025. This breakthrough reinforces Vertex’s research capabilities in advancing therapies for kidney diseases, drawing strong interest from hedge funds and analysts alike as...",
    "url": "https://finance.yahoo.com/news/kidney-disease-trial-success-might-031341845.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "dc2e8eb1-a099-3fe6-835f-a7d02493771d",
      "content": {
        "id": "dc2e8eb1-a099-3fe6-835f-a7d02493771d",
        "contentType": "STORY",
        "title": "Kidney Disease Trial Success Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)",
        "description": "",
        "summary": "Vertex Pharmaceuticals recently reported positive clinical trial data for povetacicept in IgA nephropathy and primary membranous nephropathy, showing significant proteinuria reduction and stabilization of kidney function, and announced plans to begin rolling regulatory submissions for potential FDA accelerated approval in 2025. This breakthrough reinforces Vertex’s research capabilities in advancing therapies for kidney diseases, drawing strong interest from hedge funds and analysts alike as...",
        "pubDate": "2025-11-28T03:13:41Z",
        "displayTime": "2025-11-28T03:13:41Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ihFoSuY9PLXURl2kI_sV.w--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bIz6sh0rX4c7ACsVP8z51w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/be31617c737d47553e0bc442fa8fa6d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kidney-disease-trial-success-might-031341845.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kidney-disease-trial-success-might-031341845.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-28T11:25:04+00:00",
    "headline": "Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?",
    "summary": "Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.",
    "url": "https://www.barchart.com/story/news/36355382/is-vertex-pharmaceuticals-stock-underperforming-the-nasdaq",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "93f550f3-482a-3a27-bb64-1c7c73ff51bf",
      "content": {
        "id": "93f550f3-482a-3a27-bb64-1c7c73ff51bf",
        "contentType": "STORY",
        "title": "Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq?",
        "description": "",
        "summary": "Vertex Pharmaceuticals has underperformed the broader Nasdaq index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.",
        "pubDate": "2025-11-28T11:25:04Z",
        "displayTime": "2025-11-28T11:25:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/c67ca0ce21e47cc43676e5a55d771ea0",
          "originalWidth": 1000,
          "originalHeight": 666,
          "caption": "Vertex Pharmaceuticals, Inc_ HQ in Boston-by Tada Images via Shuttershock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Shb7JdZjS3KjsEy4OVFfew--~B/aD02NjY7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/c67ca0ce21e47cc43676e5a55d771ea0.cf.webp",
              "width": 1000,
              "height": 666,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/EMGmPiWDsIHqjC0QyY.H8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/c67ca0ce21e47cc43676e5a55d771ea0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/36355382/is-vertex-pharmaceuticals-stock-underperforming-the-nasdaq",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/vertex-pharmaceuticals-stock-underperforming-nasdaq-112504825.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VRTX"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]